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A large body of evidence has emerged linking stressful experiences, particularly from one's social
environment, with psychiatric disorders. However, vast individual differences emerge in susceptibility to
developing stress-related pathology which may be due to distinct differences in the inﬂammatory
response to social stress. Furthermore, depression is an independent risk factor for cardiovascular dis-
ease, another inﬂammatory-related disease, and results in increased mortality in depressed patients. This
review is focused on discussing evidence for stress exposure resulting in persistent or sensitized
inﬂammation in one individual while this response is lacking in others. Particular focus will be directed
towards reviewing the literature underlying the impact that neuroinﬂammation has on neurotrans-
mitters and neuropeptides that could be involved in the pathogenesis of comorbid depression and
cardiovascular disease. Finally, the theme throughout the review will be to explore the notion that stress-
induced inﬂammation is a key player in the high rate of comorbidity between psychosocial disorders and
cardiovascular disease.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Depression is one of themost commonpsychosocial disorders in
the United States, affecting nearly 7% of adults andmore than 10% of
adolescents (National Institute of Mental Health, 2013a,b).
Approximately 10e30% of those suffering from depression exhibit
treatment resistance (Al-Harbi, 2012), which has been linked to an
increase in circulating cytokines (Maes et al., 1997; Musselman
et al., 2001b; Miller et al., 2002; Alesci et al., 2005; Motivala
et al., 2005; Raison et al., 2013). Although much of what is known
about inﬂammation and depression has been determined by
studying cytokine levels in the plasma, elevated pro-inﬂammatory
cytokines are also reported in the cerebrospinal ﬂuid (CSF) of
subpopulations of depressed patients (Sasayama et al., 2013; Kern
et al., 2014; Devorak et al., 2015). It has only recently been shown
for the ﬁrst time using positron emission tomography that micro-
glial activation is increased in the brains of depressed patients
compared to healthy controls, and was positively correlated with
severity of depressive symptoms (Setiawan et al., 2015). Together
these data indicate that the alterations in inﬂammatory markers
exhibited by a subset of depressed patients represent a complex
dysfunction of the immune system incorporating both the brain
and the body. Furthermore, suffering from depression greatly in-
creases the risk of developing other inﬂammatory-related medical
disorders such cardiovascular disease (CVD), which may be
precipitated by the same systems involved in depression (Seligman
and Nemeroff, 2015). A major focus of this review is to elucidate the
impact that neuroinﬂammation can have on neurotransmitters and
neuropeptides within the brain that are linked to depression and
exhibit neurogenic control of cardiovascular function, thereby
providing a window into how inﬂammation within the brain could
not only contribute to psychiatric illness, but also increase risk for
CVD.
2. Social stress and coping in humans
Social stress such as bullying, abuse, or taking care of a termi-
nally ill loved one is the most common type of stress individuals
will face in their lifetime (Almeida, 2005) and personal perception
of a social stressor is predictive of whether one will develop
depressive symptoms (Nicolai et al., 2013). Additionally, patients
suffering a depressive episode or in remission from depression
exhibit increased sensitivity to social stressors encountered in daily
life, indicating the robust nature of this stressor (van Winkel et al.,
2015). Social stress and depression can affect anyone regardless of
age, gender, ethnicity, or socio-economic background; however
only a portion of the population is susceptible. The phenomenon by
which stress exposure leads to psychosocial disorders in one indi-
vidual while another remains resilient is well recognized, however,
the mechanisms driving these individual differences are not well
understood. One factor related to susceptibility and resiliency is the
individual coping style adopted to deal with the stressor. In bothanimals and humans it has long been suggested that two diverse
coping responses to social stress can be distinguished (Henry and
Stephens, 1977). Active coping, originally described by Walter
Cannon (Cannon, 1915) is characterized as the ﬁght or ﬂight
response, while passive coping is characterized by low levels of
aggression and heightened immobility (Engel and Schmale, 1972).
In humans, the use of passive coping strategies, such as avoidance,
withdrawal, and seeking excessive reassurance/negative feedback,
has been correlated to a greater susceptibility of developing
depression (Cambron et al., 2009; Cairns et al., 2014); while active
coping, such as problem solving, seeking support, and engaging in
adaptive processes has been related to resiliency (Cairns et al.,
2014). In addition, it has been shown that patients who more
readily adopt passive coping strategies are not only more suscep-
tible to developing depression, but also exhibit greater lipopoly-
saccharide (LPS) stimulated IL-6 release fromwhole blood samples
as compared to patients who more commonly adopt active coping
strategies (Bouhuys et al., 2004). Thus since different coping stra-
tegies result in unique inﬂammatory responses, coping may be
related to the physiological consequences associated with stress
exposure and may contribute to comorbid medical disorders such
as CVD.
The impetus for this review is to investigate evidence of in-
ﬂammatory responses that are tightly coupled to individual dif-
ferences in stress susceptibility. Particular focus will be directed
towards reviewing the literature underlying the impact that stress-
related neuroinﬂammation has on neurotransmitters and neuro-
peptides that could be involved in the pathogenesis of comorbid
depression and cardiovascular disease. Given the clinical relevance
of studying the inﬂammatory response under conditions of social
stress, our literature review focused mainly on studies utilizing
modiﬁed resident-intruder models of social defeat stress. It is
important to note that the visible burrow system is another highly
relevant social stress model that provides signiﬁcant insight into
social stress (Blanchard and Blanchard, 1989; Blanchard et al., 1995;
McEwen et al., 2015); however, due to the lack of studies investi-
gating inﬂammation with this model, it does not fall within the
scope of this review.
3. Modeling social stress and coping in rodents using
repeated social defeat stress
The resident-intruder paradigm, originally developed byMiczek
(Miczek, 1979), takes advantage of the social hierarchy and the
continuing struggle for male dominance intrinsic to rodents (rats,
mice, prairie voles) in order to model the effects of social stress
(Buwalda et al., 1999; Bhatnagar and Vining, 2003; Berton et al.,
2006; Trainor et al., 2010, 2011; Wood et al., 2010; Trainor et al.,
2011). Social stress, however, is not limited to rodents and has
been demonstrated in tree shrews and other non-human primates
(Shively andWillard, 2012). Since one of the ﬁrst descriptions of the
resident-intruder model of social stress (Miczek, 1979), many
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which often involves placing a male “intruder” into the home cage
of an unfamiliar more aggressive male “resident” for 5e60 min
(Sgoifo et al., 1996; Buwalda et al., 1999; Bhatnagar and Vining,
2003; Berton et al., 2006; Krishnan et al., 2007; Wood et al.,
2010; De Miguel et al., 2011; Gomez-Lazaro et al., 2011). These
models of repeated exposure to acute (minutes to hours) social
stress have consistently been shown to result in robust activation of
the sympathetic nervous system, increased susceptibility to
arrhythmia, elevated blood pressure, increased activation of the
hypothalamic-pituitary-adrenal axis, and have been shown to
disrupt a variety of other physiological endpoints which are rele-
vant in the study of human pathology (Tornatzky and Miczek, 1993,
1994; Sgoifo et al., 1996; Bhatnagar et al., 2006; Wood et al., 2010,
2012; Carnevali et al., 2013; Sgoifo et al., 2014).
Similar to humans, stress exposure has been shown to result in
ethologically relevant passive and active coping behaviors in ﬁsh,
rodents, pigs, and non-human primates (Koolhaas et al., 1999,
2007; Sih et al., 2004; Bell, 2007; Koolhaas et al., 2007; Reale
et al., 2007). We and others have demonstrated the utility of the
resident-intruder paradigm to study the differential consequences
associated with the emergence of active and passive coping re-
sponses in the context of repeated social defeat exposure (Korte
et al., 1992; Fokkema et al., 1995; Gomez-Lazaro et al., 2011;
Wood et al., 2012; Chaijale et al., 2013; Perez-Tejada et al., 2013;
Reyes et al., 2015; Wood et al., 2015). Analysis of behavior exhibited
during defeat, such as immobility and exploration (De Miguel et al.,
2011; Gomez-Lazaro et al., 2011; Perez-Tejada et al., 2013) or
duration of upright posture and the latency to exhibit a supine
posture signaling defeat (Wood et al., 2012, 2015; Reyes et al., 2015;
Wood et al., 2015) can be used to statistically separate animals into
passive or active subpopulations. Speciﬁcally, passive coping ro-
dents are characterized by high levels of immobility, reduced
exploratory behavior, little time spent in upright postures, and a
short latency to display supine postures in response to an attack by
the resident (De Miguel et al., 2011; Gomez-Lazaro et al., 2011;
Wood et al., 2012; Perez-Tejada et al., 2013; Reyes et al., 2015;Wood
et al., 2015), which is associated with the development of
depressive-like behavioral endpoints as evidenced by increased
immobility in the forced swim test (Wood et al., 2010; Gomez-
Lazaro et al., 2011; Perez-Tejada et al., 2013) and reductions in su-
crose preference (Wood et al., 2015). In addition, passive coping
rodents generally display low plasma norepinephrine (NE) (Korte
et al., 1992; Perez-Tejada et al., 2013) and high plasma corticoste-
rone concentrations during stress (Wood et al., 2010; De Miguel
et al., 2011; Gomez-Lazaro et al., 2011). In contrast, active coping
rodents spent more time attacking/threatening the resident, spend
greater time in upright postures and generally resist defeat. Inter-
estingly, active coping rats do not exhibit the same behavioral
deﬁcits evident in passive coping rats and tend to show lower
plasma corticosterone, increased noradrenergic responsivity dur-
ing stress, and greater sympathetic activity in response to social
defeat as compared to their passive counterparts (Fokkema et al.,
1995; Wood et al., 2010; De Miguel et al., 2011; Gomez-Lazaro
et al., 2011; Perez-Tejada et al., 2013). Even though the differen-
tial consequences to stress exposure based on coping have been
well established in rodents and parallels what is seen in humans,
the neurobiological mechanisms driving these differences are not
well understood.
In addition to assessing the coping response, many labs measure
individual differences based on other social behaviors or behavioral
responses to a subsequent stressor. For example, categorizing rats
based on dominant versus submissive pairs assesses the different
behavioral responses between conspeciﬁcs as they establish a
dominant or submissive relationship during the defeat exposure.Dominants or winners are generally more resilient to the conse-
quences of social defeat and exhibit greater aggressive behavior
during the defeat exposure (Morrison et al., 2014; Stewart et al.,
2015). Other groups categorize mice as susceptible or non-
susceptible based on changes in social interaction following
repeated social defeat exposure (Krishnan et al., 2007; Hodes et al.,
2014). Unlike other methods for determining individual differ-
ences, the high/low responder method exposes animals to a novel
environment prior to stress exposure and animals deemed as high
responders exhibit greater locomotion in the novel environment
compared to low responders (Calvo et al., 2011; Duclot et al., 2011;
Hollis et al., 2011; Kumar et al., 2014). In general, low responders
exhibit a greater resilience to the consequences of social stress as
measured by the open ﬁeld, social interaction, and sucrose prefer-
ence tests (Calvo et al., 2011; Duclot et al., 2011; Hollis et al., 2011;
Kumar et al., 2014). However, opposing data also suggests that high
responders that exhibited greater active coping during defeat could
be more susceptible to developing depressive-like behavior (Calvo
et al., 2011). Although the methods of determining individual dif-
ferences varies and each has inherent advantages and disadvan-
tages, they all provide valuable insight into the dichotomy which
exist in susceptibility to social stress and parallel many of the dif-
ferences seen in the human population.
3.1. Modeling gender differences in social stress
There is a growing body of evidence on health disparities be-
tween women and men, with women being strikingly more sus-
ceptible to developing stress-related psychosocial disorders
including depression (Hankin et al., 1998), anxiety (Lewinsohn
et al., 1998), and post-traumatic stress disorder (Breslau, 2002).
Women have been shown to bemore sensitive to stress with regard
to housing problems, loss of a conﬁdant, andmarital stress (Kendler
et al., 2001; Derry et al., 2013) and are more likely to suffer con-
sequences from childhood bullying (Takizawa et al., 2015). Inter-
estingly, acute injectionwith endotoxin has shown that women are
also more susceptible to inﬂammatory-induced depressive
behavior (Moieni et al., 2015). Animal studies investigating the ef-
fect of social stress in females are severely lacking due to the
challenge of running social defeat stress in a female population. In
rats, male residents will not attack females; therefore, modiﬁed
female social defeat models have been established using highly
territorial Syrian hamsters (Huhman et al., 2003) or highly
aggressive lactating female rats (Ver Hoeve et al., 2013; Shimamoto
et al., 2015). In these studies it is unclear whether female “intruder”
rats are more sensitive to social defeat stress than male “intruders”.
In fact, Haller and colleagues directly compared the effect of social
defeat stress in males versus females on stress relevant endpoints
(weight gain, adrenal weight, plasma corticosterone) and revealed
that males were more sensitive to social defeat (Haller et al., 1999).
California mice also represent a useful species to study gender
differences in susceptibility to social defeat as females develop
greater social avoidance behavior and demonstrate marked
changes in central stress-sensitive molecules such brain derived
neurotrophic factor (BDNF) in response to social defeat exposure as
compared to males (Trainor et al., 2010, 2011; Greenberg et al.,
2014, Greenberg et al., 2015).
While studying social defeat in female rats is inherently chal-
lenging and may not have the same impact or intensity as in males,
other types of social stress may be better suited to study stress
susceptibility in females. For example, females have been reported
to be more sensitive to social instability stress than their male
counterparts (Haller et al., 1999). Furthermore, another body of
literature involving social isolation in prairie voles, a highly social
and monogamous rodent, has indicated that social isolation
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changes in cardiovascular function (Grippo et al., 2007, 2008).
Interestingly, the behavioral and cardiovascular changes that occur
following social isolation in female prairie voles are comparable to
those observed following social defeat in males (Sgoifo et al., 2001;
Wood et al., 2012, 2015). Importantly, the impact of social stress in
females on inﬂammatory measures is greatly needed.
4. Individual differences in social stress-induced
inﬂammation in the periphery
Social stress in humans within a laboratory setting, as modeled
by the Trier social stress test, has shown that enhanced feelings of
anxiety and depression are correlated with increases in stress-
induced inﬂammation in plasma (Carroll et al., 2011; Christian
et al., 2013). In animal studies social stress-induced inﬂammation
has been well characterized. Without taking individual differences
into account, social stress has been shown to increase the number
of macrophages and stimulate the expression of cytokine mRNA
and the release of IL-6 and TNF-a in the plasma (Wohleb et al., 2012,
2014b; Powell et al., 2013; Wohleb et al., 2014b). Furthermore, in-
dividual differences studies reveal that stress susceptible rats and
mice exhibit increased pro-inﬂammatory cytokines such as IL-6, IL-
15, IL-7, monocyte chemoattractant protein (MCP)-1, and IL-1b
(Hodes et al., 2014; Stewart et al., 2015; Wood et al., 2015). In
contrast, stress resilient rats or mice do not exhibit elevations in
proinﬂammatory cytokine expression in the plasma, but do exhibit
greater expression of anti-inﬂammatory IL-4 and IL-10 (Hodes
et al., 2014; Stewart et al., 2015). It is important to note that
determination of stress-induced inﬂammation in the plasma is
largely dependent on collection time. A study by Hodes et al. (2014)
illustrated that IL-6 was signiﬁcantly elevated 20 min after the ﬁrst
social defeat exposure in their susceptible population of mice and
although IL-6 was again elevated above controls when analyzed
48 h after the 10th and ﬁnal stress exposure, the concentration had
dropped by nearly 50%. Alternatively social defeat studies in rats
identiﬁed that defeat-induced IL-6 levels were elevated in sus-
ceptible, passive coping rats just one hour after the 5th stress
exposure and returned to normal within 24 h (Wood et al., 2015).
Furthermore, changes in MCP-1 levels, a pro-inﬂammatory che-
mokine responsible for inﬂammatory cell recruitment, were un-
remarkable just one hour after the 5th and ﬁnal defeat exposure,
yet were signiﬁcantly elevated 24 h after the 5th social defeat
exposure (Wood et al., 2015). These data indicate that although
stress induces inﬂammation in the periphery, this response may be
transient, rely heavily on collection time, and differs based on in-
dividual cytokines.
In addition to bone marrow, the spleen also functions as a
reservoir for monocytes to be released into the blood stream.
Therefore, splenic release of inﬂammatory cytokines may provide
insight into the long lasting peripheral changes that occur in
response to social stress. In many cases social stress has been
shown to cause an increase in splenic weight termed splenomegaly
(Kinsey et al., 2008; Wohleb et al., 2012, 2014b; Goto et al., 2015),
which is accompanied by increases in the number of monocytes
within the spleen and greater release of pro-inﬂammatory cyto-
kines such as IL-6 and TNF-a (Kinsey et al., 2008). While data
assessing individual differences in splenic inﬂammation in
response to social-stress is largely uncharacterized, ﬁndings by
Gomez-Lazaro et al. (2011) demonstrated that susceptible mice
generally exhibit increased splenic release of pro-inﬂammatory
cytokines (IL-6, TNF-a) when stimulated with the T-cell stimu-
lating agent concanavalin A. Our lab has recently conﬁrmed these
ﬁndings using repeated social stress in rats (Finnell et al., unpub-
lished). In contrast, a study conducted by De Miguel et al. (2011)demonstrated that resilient rats exhibited greater splenic release
of IL-1b and IL-2 as compared to passive and control counterparts.
These conﬂicting accounts of inﬂammatory responses in suscepti-
ble and resilient rats may arise from differences in the schedule and
duration of stress exposure. Based on these studies, resilient ani-
mals demonstrated a greater splenic response to acute social stress
exposure (De Miguel et al., 2011), while the maladaptive spleno-
megaly and persistent cytokine release evident in susceptible ani-
mals may develop in response to repeated social defeat exposure
(Gomez-Lazaro et al., 2011). Together these data demonstrate the
complex nature inherent in social stress-induced alterations in
peripheral inﬂammation and indicate the need for further research
speciﬁcally in the context of individual differences.
5. Individual differences in social stress-induced
neuroinﬂammation
As described in the introduction, there is considerable evidence
to suggest that elevated neuroinﬂammation occurs in subsets of
depressed patients and may be correlated to symptom severity
(Sasayama et al., 2013; Kern et al., 2014; Devorak et al., 2015;
Setiawan et al., 2015). Animal studies of social defeat stress
corroborate these ﬁndings by revealing that social stress exposure
leads to long lasting increases in not only the number of macro-
phages and activated microglia in the brain (Stankiewicz et al.,
2015), but also exaggerated activation of these cell types, promot-
ing increased expression of pro-inﬂammatory cytokines such as IL-
1b and TNF-a (Wohleb et al., 2011, 2012, 2014a). Microglia and
macrophages play a large role in the inﬂammatory response to
social defeat, yet the important distinction as to whether social
stress promotes M1 (pro-inﬂammatory) or M2 (anti-inﬂammatory)
microglial polarization has yet to be identiﬁed (Franco and
Fernandez-Suarez, 2015). In general, social defeat has been shown
to promote a pro-inﬂammatory phenotype within the brain by
increasing the expression of cytokines such as IL-1b, IL-6, and TNFa
in critical brain regions associated with depression (Audet et al.,
2011; Patki et al., 2013), which are generally secreted in high con-
centrations fromM1 type microglia (Franco and Fernandez-Suarez,
2015). Importantly, several endogenous molecules such as canna-
binoids, steroid hormones, substance P, and glucocorticoids have
been shown to promote M2 over M1 microglial activation. (Franco
and Fernandez-Suarez, 2015). Therefore, understanding the bal-
ance between these activated states in response to stress could
provide valuable insight into not only the adaptive/maladaptive
role of microglia in the central nervous system, but also alternative
treatment methods for diseases associated with high levels of
inﬂammation.
Individual differences in stress susceptibility are also evident at
the level of neuroinﬂammation. Rats characterized as susceptible
generally exhibit greater release of IL-1bwithin the locus coeruleus
(LC) (Wood et al., 2015), the major noradrenergic nucleus within
the brain that has been associated with depression (Ressler and
Nemeroff, 2000; Seraﬁni, 2012). These alterations in neuro-
inﬂammation are region speciﬁc, as this effect is not exhibited
uniformly throughout the brain. In fact, within the dorsal raphe
(DR), a major serotonergic center of the brain, IL-1b was not
elevated in susceptible rodents; however resilient rats exhibited an
adaptive decrease of IL-1b in the DR (Wood et al., 2015). Further-
more, elevated cytokines are not speciﬁc to susceptible rats;
signiﬁcantly elevated IL-1b mRNA was reported in the hypothala-
mus of resilient mice after two stress exposures over a 12 day
period (De Miguel et al., 2011). While these data seem contradic-
tory, social stress produces region speciﬁc alterations in activity
that is also contingent upon duration of stress exposure (Morrison
et al., 2014). We have previously demonstrated that susceptible and
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expressionwithin both the LC and the DR relative to control rats. In
the LC, where susceptible rats exhibited greater IL-1b mRNA levels
and resilient rats exhibited decreased IL-1b and TNF, social defeat
altered the expression of several other genes, many of which have a
role in immune or inﬂammatory processes. For example, genes
encoding for receptors of interleukin, beta-adrenergics, and neu-
ropeptide Y, as well as cytochrome P450s, Matrix metal-
lopeptidases, and cellular adhesion molecules were altered by
defeat, and in many cases were unique to susceptible rats. In
contrast, within the DR, there were nearly 2.5 times more genes
affected by stress in susceptible rats than in their resilient coun-
terparts (Wood et al., 2015). Similar to that found in the LC, there
were several inﬂammatory-related genes that were altered by
stress exposure. Of considerable interest, inducible nitric oxide
synthase, a signaling molecule involved in the pathogenesis of in-
ﬂammatory disorders was reduced by more than 6 fold in resilient
rats (vs. controls) while susceptible rats demonstrated a modest 1.8
fold reduction. This drastic decrease in iNOS in resilient rats may
represent a protective mechanism recruited during active coping
(Wong et al., 1996) as iNOS suppression has been shown to promote
M2 (anti-inﬂammatory) type microglia (Franco and Fernandez-
Suarez, 2015). While signiﬁcant differences in gene expression
patterns exist when comparing resilient and susceptible pop-
ulations, it is important to note that there are also some com-
monalities between these groups as seemingly protective effects of
changes in gene expression also emerged. For example, increased
expression of the IL-1 receptor type 2 (IL-1r2) a decoy receptor was
evident in the LC (McMahan et al., 1991; Wood et al., 2015) and
increased expression of suppressor of cytokine signaling 3 in the
ventral tegmental area was identiﬁed in both susceptible and
resilient groups (Krishnan et al., 2007).
It is important to note that repeated exposure to social stress
may be required for these robust alterations in neuroinﬂammation.
Hueston and colleagues (Hueston et al., 2011) demonstrated that
acute exposure to social stress was not effective in producing either
peripheral or central inﬂammation. However, others have deter-
mined that a single exposure to social stress can promote enhanced
neuroinﬂammation in response to a subsequent stress exposure
(Audet et al., 2011). One explanation for this time-dependent
phenomenon is neuroinﬂammatory priming, which is the mecha-
nism whereby exposure to stress sensitizes microglia and as a
result, facilitates the release of cytokines when challenged to a
subsequent stressor. This phenomenon is not further discussed in
the context of our review; however the topic is reviewed by Frank
et al. within this special issue.
6. The role of inﬂammation in promoting depressive-like
behavior
It is equivocal as to whether inﬂammation causes depression or
if it is merely a consequence of a depressive episode. However,
there is considerable evidence to point towards a causative role for
inﬂammation. The most convincing ﬁndings are that compounds
that promote inﬂammation are recognized to promote depression.
Providing insight to this causative relationship, administration of
interferon (IFN)-g, granulocyte macrophage colony stimulating
factor (GM-CSF), and IFN-a has recently been studied as a potential
treatment for various cancers (Capuron et al., 2001; Schmeler et al.,
2009). Of the many side effects associated with these treatments is
the development of transient depressive episodes in patients with
no prior history of depression (Capuron et al., 2001; Schmeler et al.,
2009). In addition, as discussed at length in this review, exposure to
psychosocial stressors that are capable of acutely and chronically
elevating inﬂammation also precipitate depressive disorders(Danese et al., 2008). Furthermore, epidemiological studies have
demonstrated that elevated inﬂammatory markers can be predic-
tive of developing depression (Gimeno et al., 2009; Felger et al.,
2013; Eraly et al., 2014). Based on these ﬁndings, researchers have
proposed that inﬂammation could be causative rather than merely
a result of suffering from depression. Indeed, using animal models,
it has been shown that stimulation of the immune system either
through injection of LPS, administration of pro-inﬂammatory cy-
tokines, or inducing a bacterial infection can result in neuro-
inﬂammation (O'Connor et al., 2003; Johnson et al., 2004; Ji et al.,
2014; Zhang et al., 2014; Biesmans et al., 2015) and the develop-
ment of depressive-like behavior as evidenced by behavioral
despair (O'Connor et al., 2003; Ji et al., 2014; Zhang et al., 2014; Zhu
et al., 2015) or anhedonia (Kaster et al., 2012; Ji et al., 2014; Zhang
et al., 2014). Importantly, studies from our lab have highlighted the
causal role that cytokines play in social stress-induced depressive-
like behavior as blocking IL-1b in the brain prior to each daily
exposure to social stress had no effect on the individual differences
in coping strategy, however it prevented the development of
anhedonia in susceptible rats (Wood et al., 2015). The speciﬁc roles
that cytokines play in discrete brain regions are beginning to be
unraveled and point towards cytokines affecting neurochemicals
and neuronal activation of select brain regions. The concept that
inﬂammation may mediate the development of depressive
behavior by altering central neurotransmitter activity and the ﬁring
rates of key brain regions is discussed in detail later in this review
(see Section 8).
7. Stress-induced neuroinﬂammation as a vehicle for
promoting depression-CVD comorbidity
It was ﬁrst noted byMaltzberg almost 80 years ago, that patients
suffering from depression were at increased risk of mortality
(Maltzberg, 1937). In recent years there is an unmistakable asso-
ciation between stress-related psychosocial disorders and cardio-
vascular disease, revealing amechanism for the increasedmortality
in depressed patients (Seligman and Nemeroff, 2015). Considerable
evidence points towards the role that passive stress coping may
play in susceptibility to depression, thereby linking passive stress
coping with increased susceptibility to CVD. In fact, independent of
depressive measures, some evidence exists for the role of passive
stress coping in increased vulnerability to hypertension (Harburg
et al., 1964) and psychosocial stress is also capable of promoting
atherosclerosis (Black and Garbutt, 2002), likely mediated in part
by inﬂammatory leukocytes (Heidt et al., 2014). Because inﬂam-
mation plays a key role in the pathogenesis of both hypertension
(Savoia and Schiffrin, 2006) and atherosclerosis (Black and Garbutt,
2002), inﬂammatory mediators lie at the intersection between
depression and CVD and under conditions of stress, may promote
the comorbidity between these two disorders. The link between
inﬂammation in the peripheral tissues or plasma and CVD is not a
novel concept and has been reviewed extensively. Therefore in this
review we will focus on how changes in neuroinﬂammation have
the potential to impact on neurotransmitters or neuropeptides
within the brain to mediate neurogenic mechanisms that could
promote CVD.
Animal studies have revealed a role for central inﬂammation in
cardiovascular responses as injection of IL-1b in the brain increases
blood pressure (Ye et al., 2000). Furthermore, centrally adminis-
tered IL-1ra blunts the pressor response to air jet stress and foot-
shock. In addition, the role of brain IL-1b in this stress-induced
pressor response was conﬁrmed by revealing that intravenous in-
jection of IL-1ra was ineffective (Zou et al., 2001; Ufnal et al., 2008).
In support of the role of endogenous IL-1b in depression-CVD co-
morbidity, we have identiﬁed that the susceptible (passive coping)
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signiﬁcant decreases in resting heart rate variability, indicative of
increased sympathetic activity and decreased parasympathetic
tone (Wood et al., 2012). Importantly, these changes in heart rate
variability are evident in depressed patients and are known to be an
independent risk factor for cardiac mortality (Carney et al., 1995).
More recently, within our lab we have also identiﬁed that stress
susceptible rats exhibit persistent increases in resting blood pres-
sure throughout the 12-hr dark cycle compared with controls and
their resilient counterparts (Lombard et al., unpublished results).
Given that this is the same model that we reported increased IL-1b
present in the brains of susceptible rats, it highlights an association
between stress-induced increases in endogenous IL-1b and
increased blood pressure (Fig. 1). While the direct role of central IL-
1b in hypertension is unclear, Section 8 of this review attempts to
elucidate how inﬂammation within the brain could impact on
neurobiological substrates that could contribute to exaggerated
CVD risk.Fig. 1. Behavioral and physiological stress-related consequences are unique to the copin
cope with stress, rodents have also been shown to demonstrate distinct differences in the
phenotypic response to stress, such as demonstrating active (upright postures, resisting attac
associated with differing stress-related consequences. Inﬂammatory consequences: Passiv
coping is related to a balanced inﬂammatory system. Behavioral consequences: Passive co
maintain hedonic behavior. Cardiovascular consequences: Exposure to social defeat stress in
heart rate variability and increased resting blood pressure. Active coping is related to norm8. Effect of neuroinﬂammation on neurobiologic substrates
underlying depression and cardiovascular control
The pathogenesis of stress-related psychiatric disorders and
comorbid cardiovascular disease is multifaceted andmay likely be a
result of a complex interaction between stress-sensitive neuro-
peptides/neurotransmitters and inﬂammation. Although several
lines of evidence support the hypothesis that increased inﬂam-
mation may be causal to depression and CVD, it is not yet under-
stood whether inﬂammatory factors also initiate the many
neurobiological changes accompanying these disorders. Central
nervous system alterations of serotonin (5-HT), norepinephrine
(NE), corticotropin-releasing factor (CRF), and brain derived neu-
rotrophic factor (BDNF) have all been documented in subsets of
depressed patients andmany of these have a cardiovascular impact.
Once they reach the brain, either through primary production or
passage to the brain from the periphery, inﬂammatory factors can
regulate levels of each of these neurotransmitters/neuropeptides
and therefore serves as a putative mechanism by which changes in
inﬂammation may promote susceptibility or resilience to psychi-
atric disorders (Fig. 2). In many cases there is a bidirectional rela-
tionship between these neuropeptides/neurotransmitters andg strategy adopted during social defeat. Consistent with the strategies humans use to
behavioral coping response to social stress. Phenotype: Individual differences in the
ks) versus passive (rapid supine postures in presence of resident) coping responses, are
e coping rats exhibit an imbalance towards pro-inﬂammatory responses while active
ping rats display anhedonia following social stress exposure, while active coping rats
passive coping rats manifests cardiovascular dysfunction as evidenced by a decrease in
al cardiac function in the face of 5e7 days of repeated social defeat stress.
Fig. 2. Impact of neuroinﬂammation on stress-sensitive neurobiologic molecules. Inﬂammatory cytokines have several documented effects on various neurobiological sub-
strates related to depression and CVD. (A) Inﬂammation has largely stimulatory effects on CRF and NE while it generally serves to suppress 5-HT and BDNF along with BDNF's
activated receptor, phosphorylated TrkB. We hypothesize that a milieu of elevated inﬂammation initiates a cascade of adaptations within these stress sensitive systems to contribute
to a susceptible phenotype that is primed to develop depression and CVD. (B) In the event that stress exposure does not result in persistent increases in inﬂammation, these
neurobiologic systems remain largely unaffected, thereby protecting the individual. *It should be noted that the depicted inﬂammation-induced changes in BDNF represent the
most simplistic of interpretations and in fact, certain changes in BDNF are more likely to be region speciﬁc.
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focused on the impact that inﬂammatory factors have on these
systems. In addition, central injections of cytokines (ie., IL-1b) are
capable of producing cardiovascular responses, including increased
blood pressure (Ye et al., 2000). Therefore, within each section we
also review literature on how these inﬂammation-driven neuro-
biological changes may contribute to CVD.8.1. Serotonin
The role of the serotonin system in the pathogenesis of
depression has been the basis of scientiﬁc studies for over 40 years
(Mendels et al., 1972; Mendels and Frazer, 1974). Studies measuring
monoamines in the CSF of patients treated with cytokines have
revealed that cytokine levels in CSF are correlated with serotonin
metabolites (Raison et al., 2009). A prominent effect of cytokines
within serotonergic-rich regions is the activation of indoleamine-
2,3-dioxygenase (IDO), an enzyme expressed in microglia, astro-
cytes, and neurons (Pemberton et al., 1997; Guillemin et al., 2005;
Fujigaki et al., 2006) that catabolizes tryptophan, the amino-acid
precursor to 5-HT, into kynurenine (KYN). As a result, IDO de-
creases the amount of tryptophan available to be catabolized into 5-
HT. The impact of cytokines on IDO is supported by ﬁndings that
increased KYN and decreased tryptophan and 5-HT have been
associated with the severity of depressive symptoms in patients
administered IFN-a (Raison et al., 2009). Within microgila in the
brain, KYN is metabolized to quinolinic acid which is thought to
contribute to the depressive behavioral symptoms associated with
cytokine administration. As expected, KYN levels were elevated in
plasma of IFN-a treated patients, but a recent study found this to be
associated with increased levels of KYN and quinolinic acid in CSF,
which also correlated to depressive symptoms (Raison et al., 2010).
Furthermore, selective serotonin reuptake inhibitors (SSRIs) are
therapeutically effective for depression in patients treated chroni-
cally with IFN-a, further supporting the involvement of 5-HT
dysfunction in cytokine-induced depression (Musselman et al.,
2001a). In vivo studies also support the role of the cytokine-
induced KYN pathway in depression as direct injection of KYN is
capable of producing a depressive-like effect (O'Connor et al.,
2009b) and pharmacological inhibition of IDO, or the use of IDO
deﬁcient mice, reverses the depressive-like effects of endotoxinadministration (O'Connor et al., 2009a). Although data on levels of
IDO or KYN in stress-sensitive brain regions following social defeat
have not been reported, a recent study revealed that 5-HT deﬁcient
mice exhibit enhanced susceptibility to social defeat stress (Sachs
et al., 2015).
IL-1b has also been shown to directly inhibit the ﬁring of sero-
tonergic neurons in a major serotonergic nucleus in the brain, the
dorsal raphe (DR), by enhancing GABAergic inhibitory tone
(Brambilla et al., 2007). Interestingly, we recently reported
opposing responses of serotonergic cells in the DR of stress sus-
ceptible and resilient rats following social defeat. Speciﬁcally, CRF
administration onto 5-HT cells in the DR resulted in 5-HT neuronal
inhibition in susceptible rats while this same dose of CRF produced
a robust excitatory effect in 5-HT cells of resilient rats (Wood et al.,
2013). While we conﬁrmed that this was attributed to changes in
trafﬁcking of the CRF receptor, it should be noted that resilient rats
also exhibit signiﬁcant decreases in IL-1b in the DR (Wood et al.,
2015) which may have contributed to the excitatory response of
serotonergic cells by removing IL-1b inhibitory GABAergic tone in
the DR of active coping rats. Taken together these clinical and
preclinical studies point towards a role for inﬂammation impacting
the serotonin system in a manner relevant to the pathogenesis of
depression.8.1.1. 5-HT's central regulation of cardiovascular control
In addition to its role in cytokine-induced depression, IDO ac-
tivity also correlates with risk of CVD such as atherosclerosis
(Pertovaara et al., 2007). Furthermore, depressed patients with CVD
not only exhibit elevated inﬂammation, but also exhibit increased
activation of the KYN pathway (Nikkheslat et al., 2015). These
studies did not assess kynurenine or IDO levels in the brain, how-
ever this suggests that altered tryptophan catabolism may be
involved in CVD. 5-HT also has direct cardiovascular effects within
the brain and the effects are highly brain region and receptor
subtype speciﬁc. For example, agonist activation of the 5-HT1A
receptor in the dorsal raphe nucleus produces vagally-mediated
bradycardia and hypotension (Connor and Higgins, 1990).
Furthermore, microinjection of 8-hydroxy-DPAT, a 5-HT1A agonist,
into themedullary raphe attenuates stress-induced tachycardic and
pressor responses (Nalivaiko et al., 2005; Ngampramuan et al.,
2008). Alternatively, central 5-HT2C receptors have been
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restraint stress in rats (Ferreira et al., 2005) in the nucleus tractus
soliatrius. Furthermore, 5-HT3 receptors located within the sym-
pathetic ganglia may likely regulate stress-induced hypertension
(Alkadhi et al., 1996). 5-HT central control of stress-induced car-
diovascular responses is highly complex and has been thoroughly
reviewed by (Nalivaiko and Sgoifo, 2009). Taken together, inﬂam-
mation has demonstrated ability to alter the 5-HT system in the
brain, and is therefore yet another inﬂammation-sensitive neuro-
transmitter that has the capacity to promote comorbidity between
depression and CVD either through altered receptor activation or
shifts in tryptophan catabolism via the IDO/kynurenine pathway.
8.2. Norepinephrine
The original catecholamine hypothesis of major depression
suggested that depression was associated with NE deﬁciency;
however more recent ﬁndings of melancholic depressed patients
suggest the contrary. For example, CSF levels of NEwere found to be
elevated in depressed patients over that of non-depressed patients
(Roy et al., 1985) and these results were conﬁrmed for hourly in-
tervals for 24 h a day (Wong et al., 2000). A rise in central NE was
paralleled by elevated NE levels in the plasma and both central and
peripheral NE levels normalized after successful treatment with
electroconvulsive therapy (Gold et al., 2005). Although there is
support for absolute changes in NE levels promoting psychiatric
disorders (ie., melancholic depression) it is more likely that a dy-
namic dysregulation of this system contributes to stress-related
psychiatric disorders. Alterations in the number and distribution
of NE transporters have been identiﬁed and alterations in receptor
binding have also been related to depression (Ressler and Nemeroff,
2000). To our knowledge, concomitant measurements of cytokine
and NE levels in CSF of depressed patients or measurement of NE
levels in patients treated with cytokines have not been conducted.
However, a positive correlation between IL-6 levels and NE has
been demonstrated in PTSD patients, another psychosocial disorder
that is frequently associated with elevated inﬂammation (Baker
et al., 2001).
Animal studies have shed light on the direct effect of cytokines
on central NE levels. While proinﬂammatory cytokines have been
shown to have an inhibitory effect on NE in brain regions regulating
reproduction, several reports indicate that cytokines increase NE
levels in stress-related brain regions. For example, IL-1b or IL-2
increased NE levels in stress-associated brain regions such as the
central nucleus of the amygdala, paraventricular nucleus and pre-
frontal cortex (Lacosta et al., 2000; Sirivelu et al., 2012). One
manner bywhich cytokines could stimulate NE levels in the brain is
by direct effects on LC-NE neurons, the major source of NE to the
brain. Microinjection of IL-1b or LPS into the LC increases the ac-
tivity of these noradrenergic neurons (Borsody and Weiss, 2002,
2004) and the effect of LPS injection increased LC neuronal activ-
ity for at least 7 days after a single injection (Borsody and Weiss,
2004). Increased LC activity following cytokine administration
likely results in concomitant release of NE to the expansive network
of LC targets within the brain. Interestingly, a susceptible subset of
socially defeated rats exhibit elevated cytokine levels in the LC
(Wood et al., 2015) and a recent publication from Reyes and col-
leagues using this same social defeat model revealed increased
defeat-induced LC activity in susceptible rats (Reyes et al., 2015).
Treatment with an IL-1 receptor antagonist has been shown to not
only reverse the LPS-induced increase in spontaneous discharge
rate (Borsody and Weiss, 2002, 2004) but also prevents the emer-
gence of defeat-induced depressive like behavior (Wood et al.,
2015), further supporting the role of endogenous IL-1b in stress-
induced depressive-like responses. In sum, cytokines havediscrete and dynamic effects on NE synthesis and release, which
may drive various aspects of stress-related psychiatric disorders.
8.2.1. LC-NE's central regulation of cardiovascular control
Historically studies have been equivocal regarding the func-
tional effect of LC-NE activation on peripheral cardiovascular ac-
tivity. With peptidergic-induced activation or electrical stimulation
of LC-NE neurons reported to elicit increased sympathetic nervous
system activity (Crawley et al., 1980; Brown, 1986; Paakkari et al.,
1987), while chemical activation of LC neurons either suppressed
(Sved and Felsten, 1987) or increased blood pressure (Chen and
Huang, 1997). We now understand these conﬂicting ﬁndings
likely arose in part from differences in rodent strains, awake versus
anesthetized animals, or different types of anesthesia (Kawamura
et al., 1978; Sved and Felsten, 1987; Chen and Huang, 1997). More
recent advances using optogenetic stimulation of LC-NE neurons
revealed a direct inhibition of the cardioinhibitory vagal neurons
within the dorsal motor nucleus of the vagus (Wang et al., 2014).
Furthermore, the nucleus ambiguus also reduces heart rate and
blood pressure by suppressing the sympathoexcitatory rostroven-
trolateral medulla (McKitrick and Calaresu, 1996). Similar to the
dorsal motor nucleus, the LC also projects to the nucleus ambiguus
and inhibits its activity (Jones and Yang,1985; Samuels and Szabadi,
2008b, a) thereby removing the inhibitory inﬂuence over the ros-
troventrolateral medulla. Optogenetic activation of astrocytes was
used to promote the release of L-lactate into the LC, thereby acti-
vating LC-NE neurons. Furthermore, this study revealed that acti-
vation of LC-NE neurons by L-glutamate or L-lactate increased heart
rate and blood pressure (Tang et al., 2014). Therefore, as functional
evidence of the combined effects of the excitatory inﬂuence on
sympathetic neurons and inhibitory inﬂuence on parasympathetic
neurons, selective stimulation of LC-NE neuronal projections as
produced by IL-1b, can result in peripheral catecholamine release
and increased heart rate and blood pressure (Kawamura et al.,1978;
Gurtu et al., 1984; Drolet and Gauthier, 1985). Therefore, persistent
elevations in central IL-1b that serve to increase LC ﬁring could
promote comorbid hypertension and depressive-like responses,
representing another mechanism by which inﬂammation can
promote the pathogenesis of both depression and CVD.
8.3. Corticotropin-releasing factor
Corticotropin-releasing factor (also called corticotropin-
releasing hormone) is a stress-sensitive neuropeptide that is
expressed ubiquitously throughout the central nervous system
(Owens and Nemeroff, 1991). Since its discovery by Wiley Vale and
colleagues in 1981 (Vale et al., 1981), CRF has become known for its
role in nearly every stress-related response, from stress-induced
endocrine responses, to behavior and cardiovascular responses
(Bale and Vale, 2004; Wood and Woods, 2007). Evidence from
clinical studies indicates that CRF is increased in the CSF of
depressed patients, implicating CRF in the pathogenesis of
depressive disorders (Nemeroff et al., 1984; Arborelius et al., 1999;
Holsboer and Ising, 2008). Importantly, inﬂammation has a facili-
tative effect on the CRF system. For example, inﬂammation in-
creases activation of the hypothalamic pituitary adrenal axis, the
neuroendocrine pathway that is initiated by CRF (Calogero et al.,
1988). This effect is driven, in part by CRF, because a CRF antago-
nist blocks the stimulatory effect of IL-6 and TNF-a on the HPA axis
(van der Meer et al., 1996). In addition, studies have identiﬁed that
IL-6 is co-expressed with CRF within the paraventricular nucleus
(Ghorbel et al., 2003) and IL-6 produced within this region stimu-
lates CRF gene expression (Kageyama and Suda, 2009). Interest-
ingly, post mortem studies revealed increased CRF-
immunoreactive neurons in the paraventricular nucleus of
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While this study did not measure immune factors within this re-
gion, it begs the question as to whether or not elevated cytokines
can promote the increased CRF levels observed in the depressed
patients. In addition, although outside the scope of this review, it
should be noted that CRF is the initiating factor in the hypothalamic
pituitary adrenal axis that stimulates the release of glucocorticoids.
Although it is unknown whether inﬂammation can alter glucocor-
ticoid release or function, glucocorticoids have been shown to play
a role in neuroinﬂammatory priming (Frank et al., 2015).
8.3.1. CRF's central regulation of cardiovascular control
Central CRF also represents another stress-sensitive neuropep-
tide that serves the dual purpose of promoting depressive and
anxiety-like behaviors and regulating cardiovascular activity
(Wood and Woods, 2007). Central injections of CRF are well
recognized as producing a marked pressor response and tachy-
cardia (Briscoe et al., 2000; Nijsen et al., 2000) and CRF over-
expressing mice exhibit increased heart rate and decreased heart
rate variability (Dirks et al., 2002). Exaggerated central CRF tone has
also recently been identiﬁed in stress susceptible socially defeated
rats (Reyes et al., 2015). Retrograde labeling studies were conducted
in response to 5 daily social defeat exposures and revealed that
stress susceptible rats exhibited increased activity of LC-projecting
CRF neurons in the central amygdala above that of control and
resilient rats (Reyes et al., 2015). It is unknown, however, whether
increased inﬂammation occurred in the central amygdala within
this subset of rats to produce the increase in CRF or whether car-
diovascular function was altered as a result. None-the-less, while
CRF serves to activate LC neurons this may be another mechanism
by which stress increases LC- NE activity in stress susceptible rats.
Taken together, stress-induced changes in the CRF system repre-
sents yet another mechanism by which inﬂammation may impact
on a neuropeptide system that is capable of producing both
depressive-like behaviors and CVD.
8.4. Brain-derived neurotrophic factor
BDNF is a growth factor traditionally associated with neuronal
cell growth, function, and learning; furthermore, it has also been
associated with the regulation of serotonin, choline, and dopamine
(Russo-Neustadt, 2003; Pivac et al., 2012). In addition, stress has
reliably been shown to alter the central expression of BDNF, while
antidepressants increase its expression (Duman and Monteggia,
2006; Castren et al., 2007; Schmidt and Duman, 2007, 2010). In
social defeat models, stress exposure has been demonstrated to
alter BDNF in a region speciﬁc manner with both decreases and
increases in BDNF being related to the development of depressive-
like behaviors (Berton et al., 2006; Patki et al., 2013; Der-Avakian
et al., 2014; Zhang et al., 2015). This region speciﬁcity becomes
even more complex when individual differences are considered;
rodents that were classiﬁed as resilient to social stress exhibit
robust increases in BDNF and decreases in the inactive BDNF re-
ceptor (Tyrosine receptor kinase B, TrkB, type 1) expression in the
hippocampus, while changes in BDNF are lacking in susceptible rats
(Duclot and Kabbaj, 2013). Interestingly, Duclot and Kabbaj went on
to inhibit BDNF signaling in the hippocampus of a resilient subset of
rats, which rendered their behavioral consequences comparable to
the susceptible subset of rats. Alternatively, Berton et al. (2006)
reported that ventral tegmental area-speciﬁc deletion of BDNF in
mice blocked social aversion following social defeat stress resem-
bling the effects of chronic antidepressant treatment, which
rendered the same reduction in BDNF within this brain region.
These conﬂicting accounts likely demonstrate the complex, region
speciﬁc nature of the role of BDNF in stress susceptibility. Althoughthe role of cytokines in stress-induced BDNF responses is unclear,
acute LPS injection functions to decrease the concentration of BDNF
and the phosphorylation state of BDNF's receptor, TrkB, as well as
producemorphological changes in the hippocampus and prefrontal
cortex evidenced by decreased spine density (Zhang et al., 2015;
Zhu et al., 2015).
8.4.1. BDNF's central regulation of cardiovascular control
The BDNF-TrkB signaling pathway typically serves to promote
cell survival and neuronal plasticity, however it has also been
suggested that dysfunction in its signaling cascade can increase the
spontaneous ﬁring rate of the central amygdala (Ming et al., 2013;
Prager et al., 2013), a brain region critical for the behavioral and
cardiovascular responses to stress. The role of stress-induced
changes in BDNF within the brain in the context of cardiovascular
disease is largely unexplored, however it has been determined that
peripheral levels of BDNF play a signiﬁcant role in stroke recovery
(Abramenko Iu et al., 2015; Chan et al., 2015) and contribute to
increased risk of heart failure (Takashio et al., 2015). Based on these
data, there is a strong need to understand the role that stress-
induced alterations in BDNF-TrkB signaling within the brain play
in not only depression but also cardiovascular disease.
9. Therapeutic relevance
Throughout this review we have utilized the current experi-
mental evidence to outline the putative role of neuroinﬂammation
in depression and it's high rate of comorbidity with CVD. Para-
doxically, antidepressant therapies, such as tricyclic antidepres-
sants, can in fact increase vulnerability to CVD due to the inherent
cardiotoxic effects of these drugs, not a consequence of alleviating
depression (Cohen et al., 2000). More recently, a clinical study has
revealed that antidepressant therapy in general is cardioprotective
over a 3-year period of time in patients with moderate to severe
depression but not in patients with mild depression (May et al.,
2015). Traditional antidepressant therapies such as monoamine
oxidase inhibitors, selective serotonin and norepinephrine re-
uptake inhibitors, and tricyclics function to reduce depressive
scores in a majority of depressed patients; however, these tradi-
tional treatments do not or only moderately reduce the inﬂam-
mation present in the sub-population which exhibit increased
inﬂammation (Maes et al., 1997; Sutcigil et al., 2007; Uher et al.,
2014). Animal studies have largely supported these ﬁndings. For
example, Fluoxetine blocks social stress or LPS-induced depressive
behavior (Kaster et al., 2012), while the resulting inﬂammation is
only modestly attenuated (Ji et al., 2014; Li et al., 2015; Zhu et al.,
2015).
Due to the putative role of inﬂammation in both depression and
CVD, therapies that serve to reduce neuroinﬂammation may be
beneﬁcial in select patient populations. For example, treatment
with Inﬂiximab, a TNF-a antagonist, has been shown to reduce both
depressive scores and inﬂammation in the treatment resistant
subset of patients with high baseline inﬂammation (Raison et al.,
2013). These data suggest that for this sub-population of
depressed patients it may be justiﬁed to further explore the anti-
depressant efﬁcacy of anti-inﬂammatory compounds or use an
anti-inﬂammatory as an adjuvant to traditional therapies. Although
clinical data are lacking on the efﬁcacy of natural anti-inﬂammatory
compounds in the treatment of depression, several studies using
human cell lines have found that resveratrol, one of the more
commonly used natural anti-inﬂammatory agents, can effectively
block stimulated inﬂammation (Manna et al., 2000; Falchetti et al.,
2001; Donnelly et al., 2004; Kang et al., 2009). Furthermore, animal
studies demonstrated that natural anti-inﬂammatory agents, such
as apigenin (Li et al., 2015), salidroside (Zhu et al., 2015),
J.E. Finnell, S.K. Wood / Neurobiology of Stress 4 (2016) 1e1410perillaldehyde (Ji et al., 2014), and resveratrol (Xu et al., 2010;
Ahmed et al., 2014; Hurley et al., 2014), exhibit antidepressant-
like effects. These agents generally function to reduce inﬂamma-
tion by blocking the expression of inﬂammatory progenitors (NF-
kB: Zhu et al., 2015; COX-2, iNOS: Li et al., 2015), but have also been
shown to increase the amount of serotonin and norepinephrine
available in the brain (Xu et al., 2010; Ahmed et al., 2014; Ji et al.,
2014; Zhu et al., 2015). It should also be noted that diet and exer-
cise can signiﬁcantly inﬂuence the immune system and therefore
lifestyle changes may also be useful therapy for inﬂammation-
related psychiatric disorders and cardiovascular disease
(reviewed in Nahrendorf and Swirski, 2015). Based on these ﬁnd-
ings, natural therapies with anti-inﬂammatory efﬁcacy may
represent a useful alternative therapeutic or adjuvant for depressed
patients who present with elevated inﬂammation and may likely
reduce CVD risk.
10. Conclusion
While depression is no doubt a heterogeneous disorder that
likely presents with varied pathological mechanisms, there is a
compelling relationship between psychiatric disorders and
inﬂammation (Raison et al., 2006). A great deal of focus has been
directed towards understanding whether elevated inﬂammation is
causal to depression or whether it occurs merely as a result of the
myriad of physiological alterations that accompany a depressive
episode. Several lines of evidence presented in this review suggest
that inﬂammation may be causal to depressive illness. For example,
the Whitehall II study revealed that inﬂammatory markers predict
depressive symptoms over a 12-year follow-up (Gimeno et al.,
2009). Furthermore, administration of pro-inﬂammatory agents
induce depressive symptoms in patients with no history of
depression and in laboratory animals (O'Connor et al., 2009b;
Schmeler et al., 2009; Kaster et al., 2012; Ji et al., 2014; Zhang
et al., 2015; Zhu et al., 2015). Based on the widespread studies
evaluated in this review, susceptibility to social stress is charac-
terized by an environment of enhanced inﬂammation and may
represent a mechanism promoting the comorbidity between
depression and CVD (Miller et al., 2002). We put forth the hy-
pothesis that a unique milieu of neuroinﬂammation in the context
of repeated stress exposure impacts stress-sensitive neurotrans-
mitters/neuropeptides to promote increased sensitivity to depres-
sion and co-morbid cardiovascular disease. Carefully designed
in vivo studies are needed to provide further evidence that exag-
gerated pro-inﬂammatory cytokines trigger the shared patho-
physiology resulting in depression-CVD comorbidity.
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